c-Fos gene expression pattern in the hypothalamus and the preoptic area of defeminized rats.
The object of the present study was to determine the c-fos gene expression pattern in the hypothalamus (HYP) and the preoptic area (POA) after estradiol and testosterone priming during the critical period of sexual differentiation of the rat brain. Three-day-old female rats were injected s.c. with a single dose of 17beta-estradiol (200 microg), testosterone enantate (200 microg) or vehicle (corn oil). HYP and POA were dissected 2 h, 24 h and 14 days after treatments and on the day of vaginal opening (VO). Other animals, previously treated as above, were acutely injected with 17beta-estradiol (5 microg) on the day of VO; HYP and POA were obtained 3 h later. Total RNA was extracted and processed for semiquantitative RT-PCR. We observed that c-fos gene expression was markedly increased in POA of the animals treated with estradiol or testosterone 2 h after treatments, while a non-significant increase in c-fos gene expression was observed in the HYP of these animals. We found a significant increase in c-fos expression in HYP and POA on the day of VO in both estradiol and testosterone defeminized rats. Interestingly, the acute estradiol administration on the day of VO did not induce c-fos gene expression in either HYP or POA of defeminized animals, instead a diminution in its expression was observed in animals treated with testosterone in POA. The overall results suggest that estradiol and testosterone imprinting during critical postnatal period of sexual differentiation of the brain permanently modifies the regulation of c-fos gene expression.
Arrieta
I
I
Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán 04510, México, D.F. México.
Camacho-Arroyo
I
I
Mendoza-Rodríguez
C A
CA
Cerbón
M A
MA
D000818:Animals; D003423:Critical Period, Psychological; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000502:physiology; D012739:Gonadal Steroid Hormones / Q000494:pharmacology; D007031:Hypothalamus / Q000254:growth & development / Q000502:physiology*; D011301:Preoptic Area / Q000254:growth & development / Q000502:physiology*; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics*; D051381:Rats; D017208:Rats, Wistar; D012733:Sex Differentiation / Q000187:drug effects / Q000502:physiology*; D013739:Testosterone / Q000494:pharmacology
D012739:Gonadal Steroid Hormones; D016760:Proto-Oncogene Proteins c-fos; D013739:Testosterone; D004958:Estradiol